January 21, 2010 – A new minimally invasive therapy using radiofrequency ablation to short-circuit nerves in the kidney arteries shows promise in treating uncontrolled hypertension. The research was presented this week at the International Symposium on Endovascular Therapy (ISET).

January 21, 2010 - A recent study found generic epoprostenol is a safe and effective therapy alternative to brand name Flolan for patients suffering from pulmonary arterial hypertension (PAH).

January 21, 2010 – The FDA this week cleared the HeartMate II, a continuous-flow, left ventricular assist device (VAD), as a support for severe heart failure patients who are not acceptable candidates for heart transplantation.

The HeartMate II is already FDA-approved for use in patients awaiting further, more complex treatment, such as transplants.

January 21, 2010 – The Federal Patent Court in Munich, Germany upheld the validity of Edward Lifesciences' patent for transcatheter valve technology and dismissed invalidity claims by competitor CoreValve.

January 20, 2010 - Advanced breast imaging capabilities added elastography to the list, fused MR/CT image data combined with angiography navigation systems to guide percutaneous oncology, and 3.0 Tesla MR debut at the 2009 Radiological Society of North America (RSNA).

January 20, 2010 - The IHE 2010 North America Connectathon demonstrated the efficacy of electronic health record system connectivity and interoperable exchange of patient health data with standards-based systems.

January 20, 2010 - Nearly $1 million of medical equipment and supplies donated by a leading medical manufacturer is being shipped today to Haitia for a team of Caritas Christi clinicians headed to Sacre Coeur Hospital, in Milot, Haiti, north of Port-au-Prince, to use to treat victims of the recent earthquake.

January 20, 2010 - The first FDA-cleared contrast imaging agent for use with a magnetic resonance angiography (MRA) indication to evaluate aortoiliac occlusive disease (AIOD) and suspected peripheral vascular disease enters the U.S. market today.

January 20, 2010 – The balloon material of the new REEF HP PTA Balloon Catheter was created for use in peripheral high-pressure dilatation procedures, especially to treat hard-to-dilate lesions. The balloon received FDA 510(k) clearance this week.

January 20, 2010 – A new contrast-imaging agent for use with magnetic resonance angiography (MRA) is being launched this week in the United States. ABLAVAR (gadofosveset trisodium) is the first MRA injectable imaging agent used to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease (PVD).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now